Feb 27, 2017 13:01 pm UTC| Business
National Institute for Health and Care Excellence (NICE) Publishes Final Guidance Covering Reimbursement of Galafold for Fabry Disease CRANBURY, N.J., Feb. 27, 2017 -- Amicus Therapeutics (Nasdaq:FOLD), a global...
Feb 27, 2017 13:01 pm UTC| Business
Immunomedics Intends to Implement a Non-Dilutive, Lower Risk and Potentially Higher Reward Strategy that Considers the Interests of ALL Stockholders Immunomedics’ Plan is Significantly Different from venBio’sHighly Risky...
Feb 27, 2017 13:01 pm UTC| Business
TEMPLE CITY, Calif., Feb. 27, 2017 -- Fulgent Genetics, Inc. (NASDAQ:FLGT) today announced that Ming Hsieh, Chairman and Chief Executive Officer, and Paul Kim, Chief Financial Officer, are scheduled to participate in...
Feb 27, 2017 13:01 pm UTC| Business
Both Phase 3 RECONNECT studies met co-primary endpoints and demonstrated significant improvement in key symptoms of hypoactive sexual desire disorder ...
Feb 27, 2017 13:01 pm UTC| Business
ALPHARETTA, Ga., Feb. 27, 2017 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today announced that it has...
PRGX Global Launches PRGX OPTIX™
Feb 27, 2017 13:01 pm UTC| Business
ATLANTA, Feb. 27, 2017 -- PRGX Global, Inc. (Nasdaq:PRGX), a global leader in Recovery Audit and Analytics services, today announced it has launched its PRGX OPTIX™ suite of analytics tools globally. The PRGX OPTIX...
Feb 27, 2017 13:01 pm UTC| Business
HORSHAM, Pa., Feb. 27, 2017 -- Toll Brothers, Inc. (NYSE:TOL) (www.tollbrothers.com), the nation's leading builder of luxury homes, will present to the investment community via live audio webcast at Raymond James’...